Medical specialists from France tagged as investigators in clinical trials studying Follicular Lymphoma
Total 28 results
-
Agathe Waultier-Rascalou, MDSeen in:
- Nîmes, CHU Nîmes - Carémeau
- Nîmes, CHU de Nîmes - Hôpital Caremeau
Trials:- NCT04446962 (Principal Investigator)
- NCT05529524 (Principal Investigator)
-
Benoit Tessoulin, MDSeen in:
- Nantes cedex 1, CHU NANTES - Hôtel Dieu; Service d'Hematologie Clinique
- Nantes, CHU de Nantes - Hotel Dieu
Trials:- NCT03786926 (Principal Investigator)
- NCT05529524 (Principal Investigator)
Conditions: -
Caroline MAYEUR-ROUSSE, MDSeen in:
- Strasbourg, Hematology Laboratory - Strasbourg University Hospitals
Trials:- NCT04952974 (Sub-Investigator)
-
Cécile Tomowiak, MDSeen in:
- Vienne, Poitiers, CHU Poitiers - Hôpital la Milétrie
Trials:- NCT05176691 (Principal Investigator)
Conditions: -
Cédric ROSSI, MDSeen in:
- Dijon, CHU Francois Mitterrand
Trials:- NCT03869619 (Principal Investigator)
-
Fabrice Jardin, MDSeen in:
- Haute-Normandie, Rouen, Centre Henri Becquerel
- Rouen, Centre Henri Becquerel
Trials:- NCT04224493 (Principal Investigator)
-
Fontanet Bijou, MDSeen in:
- Bordeaux, Institut Bergonie
Trials:- NCT03697512 (Principal Investigator)
- NCT03869619 (Principal Investigator)
- NCT04842877 (Principal Investigator)
Conditions: -
FRANCK MORSCHHAUSER, MDSeen in:
- Lille, Hopital Claude Huriez
- Lille, Hopital Claude Huriez; Hematologie
Trials:- NCT04531046 (Principal Investigator)
- NCT05529524 (Principal Investigator)
-
Gian Matteo Pica, MDSeen in:
- Chambéry, CH de Chambery
- Chambéry, Ch Metropole Savoie - Site Chambery
Trials:- NCT02889523 (Principal Investigator)
- NCT04842877 (Principal Investigator)
Conditions: -
Guillaume Cartron, MDSeen in:
- Cedex 05, Montpellier, CHU de Montpellier
- Montpellier, CH Saint-Eloi
- Montpellier, CHU Saint Eloi; Service d'Hématologie Clinique
- Montpellier, Hematogy Unit CHU ST ELOI
- Montpellier, Hopital Saint Eloi
Trials:- NCT01976182 (Principal Investigator)
- NCT03697512 (Principal Investigator)
- NCT04531046 (Principal Investigator)
- NCT05529524 (Principal Investigator)
- NCT06006117 (Principal Investigator)
-
Hervé Ghesquières, PrSeen in:
- Pierre-Bénite, Service d'Hématologie Clinique, Centre Hospitalier Lyon Sud, Hospices Civils de Lyon
Trials:- NCT03234140 (Principal Investigator)
Conditions: -
Jean Marc Schiano de Colella, MDSeen in:
- Marseille, Institut Paoli Calmettes
Trials:- NCT05529524 (Principal Investigator)
Conditions: -
Jean-Baptiste Robin, MDSeen in:
- Bayonne, Centre Hospitalier de La Cote Basque; Hematologie
Trials:- NCT05529524 (Principal Investigator)
Conditions: -
Kamal-Krimo BOUABDALLAH, MDSeen in:
- Pessac, CHU Haut-Leveque
Trials:- NCT03869619 (Principal Investigator)
-
Laurent MAUVIEUX, MD, PhDSeen in:
- Strasbourg, Hematology Laboratory - Strasbourg University Hospitals
- Strasbourg, Laboratoire d'Hématologie
Trials:- NCT03771079 (Principal Investigator)
- NCT04952974 (Principal Investigator)
- NCT04908059 (Principal Investigator)
- NCT03582241 (Principal Investigator)
-
Laurent MIGUET, MDSeen in:
- Strasbourg, Hematology Laboratory - Strasbourg University Hospitals
- Strasbourg, Laboratoire d'Hématologie
Trials:- NCT03771079 (Sub-Investigator)
- NCT04952974 (Sub-Investigator)
-
Loïc Ysebaert, MDSeen in:
- Toulouse, IUCT Oncopole Toulouse
- Toulouse, Institut universitaire du cancer
Trials:- NCT03697512 (Principal Investigator)
- NCT03869619 (Principal Investigator)
- NCT04333524 (Principal Investigator)
- NCT05444712 (Principal Investigator)
Conditions:- Splenic Marginal Zone Lymphoma;
- Marginal Zone Lymphoma;
- Nodal Marginal Zone Lymphoma;
- Mantle Cell Lymphoma (MCL);
- Follicular Lymphoma (FL);
- Diffuse Large B Lymphoma (DLBCL);
- Marginal Zone Lymphoma (MZL);
- T-cell Lymphoma (T-NHL);
- Hodgkin's Lymphoma (HL);
- Burkitt Lymphoma (BL));
- Peripheral T Cell Lymphoma
-
Luc-Matthieu FORNECKER, MDSeen in:
- Strasbourg, CHRU de Strasbourg
- Strasbourg, Hôpitaux Universitaires de Strasbourg
Trials:- NCT03697512 (Principal Investigator)
- NCT03869619 (Principal Investigator)
- NCT05444712 (Principal Investigator)
Conditions:- Splenic Marginal Zone Lymphoma;
- Marginal Zone Lymphoma;
- Nodal Marginal Zone Lymphoma;
- Mantle Cell Lymphoma (MCL);
- Follicular Lymphoma (FL);
- Diffuse Large B Lymphoma (DLBCL);
- Marginal Zone Lymphoma (MZL);
- T-cell Lymphoma (T-NHL);
- Hodgkin's Lymphoma (HL);
- Burkitt Lymphoma (BL));
- Peripheral T Cell Lymphoma
-
Nadine Morineau, MDSeen in:
- La Roche-sur-Yon, CHD Vendee
- La Roche-sur-Yon, CHD de Vendée
Trials:- NCT03869619 (Principal Investigator)
- NCT04842877 (Principal Investigator)
-
Olivier FITOUSSI, MDSeen in:
- Bordeaux, Polyclinique Bordeaux Nord Aquitaine
Trials:- NCT05298293 (Principal Investigator)
- NCT02889523 (Principal Investigator)
Conditions: -
Ravzan BIZOISeen in:
- Strasbourg, Hematology Laboratory - Strasbourg University Hospitals
Trials:- NCT04952974 (Sub-Investigator)
-
Remy DULERY, MDSeen in:
- Other, Paris, Hopital Saint-Antoine
- Paris, Hopital Saint Antoine; Hematologie Clinique
- Paris, Hopital Saint-Antoine
Trials:- NCT04404283 (Principal Investigator)
- NCT05529524 (Principal Investigator)
Conditions: -
Roch Houot, MDSeen in:
- Rennes, CHU Pontchaillou
Trials:- NCT05529524 (Principal Investigator)
Conditions: -
Stéphanie Guidez, MDSeen in:
- Poitiers, Hopital De La Miletrie; Hematologie Et Oncologie Medicale
Trials:- NCT05529524 (Principal Investigator)
Conditions: -
Thibaut FABACHER, MDSeen in:
- Strasbourg, Hematology Laboratory - Strasbourg University Hospitals
Trials:- NCT04952974 (Sub-Investigator)
-
Thomas Gastinne, MDSeen in:
- Loire-Atlantique, Nantes, CHU de Nantes - Hematologie
- Loire-Atlantique, Nantes, CHU de Nantes - Service d'Hématologie Clinique Place Alexis Ricordeau
- Loire-Atlantique, Nantes, Service d'Hématologie Clinique Place Alexis Ricordeau
- Nantes, CHU Nantes
- Nantes, Hospital North
Trials:- NCT04224493 (Principal Investigator)
- NCT04104776 (Principal Investigator)
- NCT04446962 (Principal Investigator)
Conditions:- Follicular Lymphoma;
- Relapsed/Refractory Follicular Lymphoma;
- Refractory Follicular Lymphoma;
- Lymphoma, T-Cell;
- Mesothelioma, Malignant;
- Advanced Solid Tumor;
- Endometrial Cancer;
- Diffuse Large B Cell Lymphoma;
- Ovarian Clear Cell Carcinoma;
- Prostatic Neoplasms, Castration-Resistant;
- Lymphoma, Large B-Cell, Diffuse;
- Central Nervous System Neoplasms, Primary
-
Vincent Ribrag, MDSeen in:
- Val De Marne, Villejuif cedex, Institut Gustave Roussy
- Villejuif, Gustave Roussy
Trials:- NCT05176691 (Principal Investigator)
- NCT04104776 (Principal Investigator)
Conditions:- Follicular Lymphoma;
- Waldenstrom Macroglobulinemia;
- Lymphoplasmacytic Lymphoma;
- NHL;
- DLBCL;
- Richter Syndrome;
- CLL/SLL;
- MCL;
- MZL;
- Lymphoma, T-Cell;
- Mesothelioma, Malignant;
- Advanced Solid Tumor;
- Endometrial Cancer;
- Diffuse Large B Cell Lymphoma;
- Ovarian Clear Cell Carcinoma;
- Prostatic Neoplasms, Castration-Resistant
-
Zora Marjanovic, MDSeen in:
- Paris, Paris cedex 12, Hopital Saint-Antoine
Trials:- NCT05176691 (Principal Investigator)
Conditions:
Clinical Trials on Follicular Lymphoma
-
Joseph TuscanoNational Cancer Institute (NCI); Genentech, Inc.; Pharmacyclics LLC.RecruitingAnn Arbor Stage II Follicular Lymphoma | Ann Arbor Stage III Follicular Lymphoma | Ann Arbor Stage IV Follicular Lymphoma | Grade 1 Follicular Lymphoma | Grade 2 Follicular Lymphoma | Grade 3a Follicular LymphomaUnited States
-
National Cancer Institute (NCI)RecruitingRecurrent Follicular Lymphoma | Refractory Follicular Lymphoma | Grade 1 Follicular Lymphoma | Grade 2 Follicular Lymphoma | Grade 3a Follicular LymphomaUnited States
-
Memorial Sloan Kettering Cancer CenterFox Chase Cancer Center; Pharmacyclics LLC.TerminatedFollicular Lymphoma | Follicular Lymphoma, Grade 1 | Follicular Lymphoma, Grade 2 | Follicular Lymphoma Grade IIIaUnited States
-
National Cancer Institute (NCI)TerminatedStage III Grade 1 Follicular Lymphoma | Stage III Grade 2 Follicular Lymphoma | Stage III Grade 3 Follicular Lymphoma | Stage IV Grade 1 Follicular Lymphoma | Stage IV Grade 2 Follicular Lymphoma | Stage IV Grade 3 Follicular LymphomaUnited States
-
Robert LowskyNational Cancer Institute (NCI); Janssen, LP; The Leukemia and Lymphoma Society; Rising Tide FoundationCompletedMantle Cell Lymphoma | Marginal Zone Lymphoma | Recurrent Follicular Lymphoma | Refractory Follicular Lymphoma | Grade 1 Follicular Lymphoma | Grade 2 Follicular Lymphoma | Grade 3a Follicular LymphomaUnited States
-
Olivia Newton-John Cancer Research InstituteBristol-Myers Squibb; Barwon Health; Austin Health; Eastern Health; Fiona Stanley... and other collaboratorsRecruitingFollicular Lymphoma Stage II | Follicular Lymphoma Stage III | Follicular Lymphoma Stage IVAustralia
-
Fondazione Italiana Linfomi ONLUSCompletedFollicular Lymphoma, Grade 1 | Follicular Lymphoma, Grade 2 | Follicular Lymphoma Grade 3AItaly
-
Epizyme, Inc.RecruitingFollicular Lymphoma | Relapsed/Refractory Follicular Lymphoma | Refractory Follicular LymphomaUnited States, China, Spain, France, Taiwan, United Kingdom, Australia, Korea, Republic of, Canada, Italy, Hungary, Poland, Belgium, Germany
-
Massachusetts General HospitalTG TherapeuticsActive, not recruitingLymphoma | Follicular Lymphoma | Marginal Zone Lymphoma | Follicular Lymphoma, Grade 1 | Follicular Lymphoma Grade IIIa | Marginal Zone B Cell Lymphoma | Follicular Lymphoma Grade 2United States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingGrade 3a Follicular Lymphoma | Ann Arbor Stage III Grade 1 Follicular Lymphoma | Ann Arbor Stage III Grade 2 Follicular Lymphoma | Ann Arbor Stage IV Grade 1 Follicular Lymphoma | Ann Arbor Stage IV Grade 2 Follicular Lymphoma | Ann Arbor Stage III Grade 3 Follicular Lymphoma | Ann Arbor Stage...United States